FAM
IDXX icon

Fulcrum Asset Management’s Idexx Laboratories IDXX Stock Holding History

Fulcrum Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-831
Closed -$232K – 281
2025
Q1 		$232K Buy
+831
New +$361K 0.05% 193

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fulcrum Asset Management's IDXX Position: Q1 2026 in Review

Fulcrum Asset Management held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 1,037 shares worth $578K. The position accounts for 0.09% of the portfolio, ranked #126.

Fulcrum Asset Management first reported a position in IDXX in Q2 2020 and has held it in 5 quarters since. The position peaked at $8.43M in Q2 2020. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Fulcrum Asset Management held 1,037 shares of Idexx Laboratories worth $578K as of Q1 2026.
  • Fulcrum Asset Management left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up 0.09% of Fulcrum Asset Management's portfolio in Q1 2026, its #126 holding.
  • Fulcrum Asset Management first reported a position in Idexx Laboratories in Q2 2020 and has held it in 5 quarters since.
  • Fulcrum Asset Management's Idexx Laboratories position peaked at $8.43M in Q2 2020.
  • 1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Fulcrum Asset Management's 13F filing for Q1 2026, filed 14 May 2026.